Walacides, Daniel
Meier, Astrid
Knöchelmann, Anne Caroline
Meinecke, Daniele
Derlin, Thorsten
Bengel, Frank M.
Ross, Tobias L.
Wester, Hans-Jürgen
Derlin, Katja
Kuczyk, Markus A.
von Klot, Christoph A. J.
Christiansen, Hans
Henkenberens, Christoph http://orcid.org/0000-0002-0721-5683
Article History
Received: 2 July 2018
Accepted: 14 December 2018
First Online: 4 January 2019
Compliance with ethical guidelines
:
: D. Walacides is a shareholder of Scintomics. A. Meier, A.C. Knöchelmann, D. Meinecke, T. Derlin,F.M. Bengel, T.L. Ross, H.-J. Wester, K. Derlin, M.A. Kuczyk,C.A.J. von Klot, H. Christiansen, and C. Henkenberens declare that they have no competing interests.
: All patients provided written informed consent prior to 68 Ga-PSMA ligand PET/CT, CT, or MRI. This retrospective study complied with the regulations of the local institutional review board and principles of the Declaration of Helsinki.